Looks interesting...more research necessary. He
Post# of 36536
Here’s one for you: I bought Todos medical about 6 weeks ago at .04 and it’s up in the neighborhood of .15 with good prospects. They’re doing what GNBT should have been doing with HEMA. At least in the near term GNBT might have bet on the wrong horse. Since covid isn’t going away anytime soon, testing is becoming a crucial tool for public health management.